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The Efficacy and Cost-Effectiveness 
of Stepped Care Prevention and 
Treatment for Depressive and/or 
Anxiety Disorders: A Systematic 
Review and Meta-Analysis
Fiona Yan-Yee Ho1, Wing-Fai Yeung2, Tommy Ho-Yee Ng3 & Christian S. Chan1
Stepped care is an increasingly popular treatment model for common mental health disorders, given 
the large discrepancy between the demand and supply of healthcare service available. In this review, 
we aim to compare the efficacy and cost-effectiveness of stepped care prevention and treatment with 
care-as-usual (CAU) or waiting-list control for depressive and/or anxiety disorders. 5 databases were 
utilized from its earliest available records up until April 2015. 10 randomized controlled trials were 
included in this review, of which 6 examined stepped care prevention and 4 examined stepped care 
treatment, specifically including ones regarding depressive and/or anxiety disorders. Only trials with 
self-help as a treatment component were included. Results showed stepped care treatment revealed a 
significantly better performance than CAU in reducing anxiety symptoms, and the treatment response 
rate of anxiety disorders was significantly higher in stepped care treatment than in CAU. No significant 
difference was found between stepped care prevention/treatment and CAU in preventing anxiety 
and/or depressive disorders and improving depressive symptoms. In conclusion, stepped care model 
appeared to be better than CAU in treating anxiety disorders. The model has the potential to reduce the 
burden on existing resources in mental health and increase the reach and availability of service.
Depressive and anxiety disorders bring severe health and financial burdens to the sufferers and the public1,2. 
Although extensive evidence has shown that psychological treatment is effective in treating depressive and anxiety 
disorders3–5, resource constraints limit its reach, especially in countries with developing economies. Per 100,000 
people in low-income countries, there are merely 5% and 4% of them that are psychiatrists and psychologists 
respectively6. Given the significant discrepancies between the demand for evidence-based psychotherapy and the 
availability of healthcare professionals7, it is crucial to make efficient use of the limited healthcare resources to 
maximize the number of beneficiaries.
Recently, stepped care model is considered as one of the possible solutions to reduce the existing healthcare 
burden8. Within the stepped care model (Supplementary Fig. S1), evidence-based psychological treatments are 
distributed to different steps9. This starts with less intensive treatments, for example, through self-help treatments 
delivered through the internet10, bibliotherapy11, and/or group therapy12, to more intensive treatments involving 
individual therapy provided by specialists13 and possibly subsequent pharmacological treatment14. Stepped care 
model as a healthcare delivery method has two core features, “least restrictive” and “self-correcting”15. “Least 
restrictive” refers to a low-intensity, cost effective, and least time consuming feature of this method and is used as 
the first-line treatment. “Self-correcting” refers to the “stepping-up” criteria that are utilized in possible prepara-
tion of more intensive and expensive treatment, and this is necessary based on treatment outcome. Patients are 
monitored systematically and referred to the next step if they do not respond significantly to the prior steps in the 
model. A care manager or psychiatric nurse is sometimes assigned to coordinate the treatment program, monitor 
the progress, and assist patients to decide the level of treatment, all of which take into account of the severity of 
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their symptoms16. The advantage of the stepped care model is that it maximizes the effectiveness and efficiency of 
treatments by optimizing resource allocation.
Currently, stepped care model is recommended in the clinical guidelines by the National Institute for Health 
and Clinical Excellence in the United Kingdom for common mental health problems8. The model has been imple-
mented and evaluated for various mental health problems such as eating disorders17, depression and anxiety18, 
obsessive-compulsive disorder19, posttraumatic stress disorder20, chronic fatigue syndrome21, nicotine depend-
ence22, and alcohol use disorders23. The findings of some of these randomized controlled trials (RCTs) support 
the clinical benefits of stepped care approach. For example, stepped care treatment was found superior than CAU 
in treating eating disorders in a 1-year follow-up17 and alcohol use disorders in a 6-month follow-up23. On the 
other hand, other clinical trials failed to show significant outcome differences between the stepped care and CAU 
groups18. Nonetheless, the stepped care model appears to be more cost effective than traditional approaches. For 
example, stepped care was more cost effective in comparison to traditional cognitive-behavioral therapy (CBT) in 
treating bulimia nervosa24. The cost per abstinent subject of stepped care and traditional CBT were USD $12,146 
and USD $20,317 respectively.
Given the potential benefits of the stepped care model on the one hand, and the structural constraints of 
traditional modes of treatment delivery on the other, it would be of interest to systematically examine its clinical 
efficacy and cost effectiveness. To our knowledge, there are only two systematic reviews that summarized the 
efficacy of the stepped care model; one for alcohol use disorders and nicotine dependence25 and the other for 
depression26. The former found little evidence to conclude that the stepped care model is superior to CAU in 
terms of treatment outcome but they recognized that this might be partially due to insufficient statistical power. 
The latter, on the other hand, found moderate effect size in treating depression, but had limited evidence to con-
clude that stepped care should be the dominant treatment model. The review by van Straten26 has summarized the 
studies on stepped care model as a treatment intervention for depression, but the review did not include studies 
on stepped care model as a preventive intervention, which has important clinical and public health implication.
There is great heterogeneity in the architecture of stepped care model, in terms of the number of steps 
and treatment components incorporated, which may limit the generalizability of the results in previous 
meta-analysis26. We argue that self-help is a crucial first treatment step in the model because of its cost effec-
tiveness and least restrictive nature. The inclusion of self-help treatment has the advantage of allowing a larger 
proportion of patients to reach the service, especially for individuals who are not able to afford pharmacotherapy 
or psychotherapy and/or those who have geographical or transportation constraints27,28. However, to date, there 
is no systematic review and meta-analysis of stepped care prevention and treatment for depressive and anxiety 
disorders that specifically investigated studies using self-help treatment as the first step in stepped care model. 
Given these knowledge gaps, we conducted a meta-analysis of RCTs that examined the efficacy of stepped care 
vis-à-vis CAU or waiting-list (WL) as a treatment or prevention intervention for depression or/and anxiety. We 
included both prevention and intervention studies. Furthermore, cost-effectiveness of stepped care approach was 
also evaluated.
Methods
Selection of Studies. Two authors (FYH and THN) independently searched electronic databases, including 
Cochrane Central Register of Controlled Trials, PubMed, PsycINFO, CINAHL Plus, and ProQuest Dissertations 
& Theses from the earliest available records to April 2015. The search terms were indicative of stepped care treat-
ment and prevention and RCTs: (psychotherapy OR psychological treatment OR cognitive-behavioral OR CBT 
OR mental OR counsel* ) AND (random* OR controlled trial OR randomized controlled trial OR RCT) AND 
(stepped care OR adjunctive treatment OR treatment tiering OR adaptive treatment). The combination of terms 
was searched by title, abstract or keyword. We also searched for additional relevant articles from the reference lists 
of retrieved papers. We did not set any restrictions for duration of treatment, outcome measure or study quality.
Studies that employed stepped care model as a treatment or prevention intervention for depressive and/or 
anxiety disorders were included in this review. Prevention referred to intervention provided to people with high 
risk or subthreshold symptoms of depressive and anxiety disorders; whereas treatment referred to intervention 
given to those with a diagnosis of a depressive and/or anxiety disorder. Our inclusion criteria were the following: 
(1) studies examining stepped care treatment or prevention in comparison with CAU or WL; (2) participants with 
depressive and/or anxiety disorders diagnosed by standard diagnostic criteria such as Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV or DSM-5) or chief complaint of depressive and/or anxiety symptoms 
assessed by standardized measures; and (3) studies with self-help as the first treatment step in stepped care model 
(i.e., “least restrictive”) without a combination of non-self-help treatments, because self-help was considered 
appropriate to be the first line treatment due to its low cost and wide availability27,29. We excluded studies with 
no “stepping-up” criteria (i.e., “self-correcting”). Collaborative care RCTs were considered as eligible if both the 
inclusion and exclusion criteria were met.
Data Extraction. Data extraction was performed by two authors (FYH and THN) independently. 
Disagreements on inclusion and exclusion were resolved through discussion. Consensus was achieved for all 
included publications. The methodological qualities in the included studies were evaluated by the Cochrane’s 
risks of bias assessment29. The risks-of-bias assessment covers six domains in evaluating RCTs, including selection 
bias, performance bias, detection bias, attrition bias, reporting bias, and other possible biases. Assessors assigned 
a judgment for each domain, which can be “yes” (low risk of bias), “no” (high risk of bias) or “unclear” (uncertain 
risk). An inter-rater reliability analysis using the Kappa statistic was performed on the quality assessment, and 
the agreement was substantial (Cohen’s Kappa = 0.76, p < 0.001). Discrepancies were resolved by discussion with 
the third author (WFY).
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Statistical Analyses. The program Review Manager (RevMan 5.2.4) was used for statistical analysis. 
Continuous outcome data were combined using either mean difference or standardized mean difference with 
95% confidence intervals (CI); dichotomous outcome data were combined using risk ratio and odds ratio with 
95% CI. Random effects model was used in view of the anticipated between-study variance29. Publication bias was 
evaluated by funnel plot if 10 or more studies were included29.
Results
Selection of Studies. There were 3093 citations identified from the search, of which 907 were identical 
citations and 2123 were irrelevant papers. A total of 63 full texts were retrieved for further review, of which 53 
articles were excluded due to the violation of inclusion criteria (Fig. 1). Of the remaining 10 RCTs included in this 
review, 6 examined stepped care prevention and 4 examined stepped care treatment. Since 2 included prevention 
studies were extensions of the other 2 already included prevention studies, the total number of included studies 
were greater than the actual number of trials described in the tables and figures. Details of the excluded studies 
are available from the authors.
Description of Included Studies. Stepped care prevention. The four stepped care prevention trials30–35 
included a total of 731 participants (sample size ranged from 136 to 240) (Table 1). Participants were elderly from 
the Netherlands with depressive or anxiety symptoms and adults from Hong Kong with subthreshold depression 
and/or anxiety. Participants’ mean age was 78.2 years and 68.6% of the sample was female. Standardized self-rating 
scales, the Center for Epidemiologic Studies Depression Scale (CES-D) and the Hospital Anxiety and Depression 
Scale–Anxiety (HADS-A) were used in three and one of the included trials for screening respectively; however, 
a different cutoff score was adopted. The remaining trial was a relapse prevention, which only included partic-
ipants who had undergone previous psychological or pharmacological treatment for depression (Study 1)30,31. 
The major inclusion and exclusion criteria are presented in Supplementary Table S1. All studies compared stepped 
care prevention with CAU. Participants had unrestricted access to any form of health care (e.g., psychological 
interventions and prescription medications) in CAU group. Treatment outcome was evaluated with self-report 
measures in all four studies and with structured diagnostic interviews in three studies.
Stepped care treatment. The four stepped care treatment trials included a total of 488 participants; the sample 
size ranged from 30 to 180 (Table 1)16,18,19,36. The average age of the participants was 43.9 years and 63.5% of the 
sample was female. Participants were adults aged ≥ 18 years from the Netherlands or United States with depressive 
and/or anxiety disorders. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
Figure 1. Selection Flow of Trials for Inclusion in the Review. 
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No.
Study 
authors 
(year)
Country/
type of 
participants
Mean age 
(SD)/ 
% female
Diagnostic 
criteria Design Collaboration
Sample 
size 
(subgroup)
Assess-
ments
Stepped care 
intervention
Control 
intervention
Outcome 
measure
Major results 
reported
Stepped Care Prevention
1 Apil  et al.30,31
Netherlands/ 
elderly with 
depression 
previously
65.8 
(8.4)/73.2%
Had received 
treatment for 
depression
2-parallel 
arms (SC, 
CAU)
Nurses 136 (74/62) 6, 12, 24 mo
1) Watchful 
waiting; 2) SH 
CBT; 3) FTF 
CBT; 4) referral 
to physicians or 
psychotherapists
CAU 
(unrestricted 
access to 
any form of 
health care)
CES-D, 
GGZ, 
Tic-P
No significant 
difference 
between SC 
and CAU in 
incidence of 
depression 
at 12-mo. SC 
required new 
treatment 
significantly> 
CAU.
2 Dozeman  et al.32
Netherlands/ 
elderly in 
residential 
homes
84.4 
(6.6)/72.9%
CES-D ≥ 
8, MINI for 
depressive 
or anxiety 
disorders
2-parallel 
arms (SC, 
CAU)
General 
practitioners, 
mental health 
specialists, 
nurses
185 (93/92) 1, 4, 7, 10 mo
1) Watchful 
waiting; 2) 
SH activity-
scheduling; 3) 
FTF life review; 
4) referral 
to general 
practitioners or 
mental health 
specialists
CAU 
(unrestricted 
access to 
any form of 
health care)
MINI, 
CES-D, 
HADS-A, 
loneliness 
scale, 
Tic-P, 
ADL, 
GARS
SC significantly 
reduced the 
risk of MDD 
incidence in 
comparison 
with CAU. 
3
van’t Veer-
Tazelaar  
et al.33,34
Netherlands/ 
elderly with 
subthreshold 
depression 
and anxiety
81.4 
(3.7)/74%
CES-D ≥ 
16, MINI for 
depressive 
or anxiety 
disorders
2-parallel 
arms (SC, 
CAU)
Nurses, 
primary care 
physicians
170 (86/84) 6, 12, 18, 24 mo
1) Watchful 
waiting; 2) SH 
CBT; 3) FTF 
PST; 4) referral 
to primary care 
physicians
CAU 
(unrestricted 
access to 
any form of 
health care)
CES-D, 
MINI
SC significantly 
halved the 
cumulative 
incidence rate 
of DSM-IV 
depression or 
anxiety at 12 
and 24-mo FU.
4 Zhang  et al.35
Hong Kong/ 
adults in 
public 
primary 
clinics
NA 
(NA)/74.2%
CES-D ≥ 16 or 
HADS-A ≥ 6
2-parallel 
arms (SC, 
CAU)
Social workers, 
family medicine 
doctors
240 
(121/119)
3, 6, 9, 
12, 15 
mo
1) Watchful 
waiting; 2) 
guided SH; 3) 
problem solving 
treatment; 4) 
family doctor 
treatment
CAU 
(unrestricted 
access to 
any form of 
health care)
CES-D, 
HADS-A
No significant 
difference 
between SC 
and CAU 
in of SCP in 
preventing the 
onset of MDD 
and GAD.
Stepped Care Treatment
5 Muntingh et al.16
Netherlands/ 
adults in 
primary care 
46.5 
(15.5)/68.3%
DSM-IV for PD 
and GAD
2-parallel 
arms (SC, 
CAU)
Care managers, 
general 
practitioners, 
psychiatrists
180 
(114/66)
3, 6, 9, 
12 mo
1) Guided 
SH CBT; 2) 
FTF CBT; 3) 
pharmacotherapy
CAU 
(unrestricted 
access to 
any form of 
health care)
BAI, 
PHQ, 
SF-36, 
EQ-5D
SC significantly 
gained more in 
BAI score than 
CAU.
6 Oosterbaan et al.36
Netherlands/ 
outpatients 
in mental 
healthcare 
centres
38.0 
(12.0)/62.0%
MINI for 
depressive, 
anxiety and 
stress-related 
disorders
2-parallel 
arms (SC, 
CAU)
General 
practitioners, 
psychologists, 
nurses
158 (94/64) 4, 8, 12 mo
1) Guided SH 
CBT in primary 
care; 2) FTF 
CBT in mental 
healthcare; 
3) intensive 
psychiatric 
treatment in day 
care clinic 
CAU 
(unrestricted 
access to 
any form of 
health care)
CGI-I, 
CGI-S, 
HRSA, 
CES-D, 
FQ, SCL-
90-R, 
SF-36
SC significantly 
superior 
to CAU 
responders at 
4-mo mid-test. 
No significant 
difference 
between SC 
and CAU at 8 
and 12-mo FU.
7 Seekles  et al.18
Netherlands/ 
primary care
50.2 
(11.2)/65%
DSM-IV for 
depressive 
and/or anxiety 
disorders/HADS 
≥ 12
2-parallel 
arms (SC, 
CAU)
General 
practitioners, 
psycholo-gists, 
psychiatric 
nurses
120 (60/60) 8, 16, 24 wk
1) Watchful 
waiting; 2) 
guided SH CBT; 
3) FTF PST; 4) 
referral/ 
pharmacotherapy
CAU 
(unrestricted 
access to 
any form of 
health care)
IDS, 
HADS, 
WSAS, 
CIDI
Both groups 
significantly 
decreased in 
depression 
and anxiety 
over time. No 
significant 
difference 
between SC 
and CAU in 
depression and 
anxiety.
8 Tolin et al.19 NR 33.9 (13.3)/58.8%
DSM-IV for 
OCD ≥ 1 year, 
Y-BOCS ≥ 16 
and CGI ≥ 4
2-parallel 
arms (SC, 
CAU)
Therapists 30 (18/12) 1, 3 mo 1) Guided SH ERP; 2) FTF ERP
Standard 
ERP
Y-BOCS, 
CGI-S 
and 
CGI-I
No significant 
difference 
between SC 
and CAU in 
Y-BOCS and 
treatment 
satisfaction.
Table 1.  Characteristics of Randomized Controlled Trials of Stepped Care Treatment and Prevention 
for Depressive and/or Anxiety Disorders. ADL, activity of daily living; BAI, Beck Anxiety Inventory; CAU, 
care-as-usual; CBT, cognitive-behavioral therapy; CES-D, Centre of Epidemiological Studies–Depression 
scale; CGI-I, Clinical Global Impression–Improvement Scale; CGI-S, Clinical Global Impression–Severity 
Scale; CIDI, Composite International Diagnostic Interview; DSM-IV, Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition; ERP, exposure and response prevention; EQ-5D, EuroQol-5D; FQ, Fear 
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was used in all trials for screening. All studies compared stepped care treatment with CAU. Participants had 
unrestricted access to any form of health care (e.g., no treatment, psychological interventions, prescription medi-
cations, referrals to psychiatric nurse, primary care psychologist, specialized mental health center or other profes-
sional) or standard exposure and response prevention (ERP)19 in CAU group. Treatment outcome was evaluated 
with self-rated or clinician-administered questionnaires.
Description of Stepped Care Content. Stepped care prevention. In the identified stepped care preven-
tion studies, all of the prevention programs consisted of 4 steps, with watchful waiting as the first step, self-help 
psychotherapy as the second step, face-to-face psychotherapy as the third step and referral to specialists as the last 
step. Self-help psychological treatments were based on CBT from the book Coping with Depression37 in all except 
one trial (Study 4)35. Various treatment contents were adopted in face-to-face psychotherapy step, including CBT, 
life review therapy and problem-solving treatment (PST) (Table 2).
Stepped care treatment. In the identified stepped care treatment studies, the treatment program consisted of 2 
to 4 steps. One study used 4 steps with the same treatment sequence as stated in stepped care prevention; one 
study used 3 steps with self-help psychotherapy as the first step, followed by face-to-face psychotherapy and 
pharmacotherapy; two studies used 2 steps with self-help and face-to-face psychotherapy. Self-help psychological 
treatments included PST, exposure therapy, ERP, and CBT. Face-to-face psychological treatments were based on 
PST, CBT and ERP. Details of the stepped care treatment content are described in Table 2.
“Stepping Up” Criteria. Stepped care prevention. “Stepping up” refers to the progression from less restric-
tive treatments to more intensive treatments if no significant health benefits were achieved. All of the four pre-
vention trials invited participants to progress to the next step if the symptom severity, as measured by CES-D and 
HADS-A, remained greater than a cutoff score (Table 2). Different cutoff scores were used across four studies: 
They were CES-D score ≥ 15, ≥ 16, less than a 5-point improvement or HADS-A ≥ 6, respectively. Direct referral 
to the last step was given to participants who had a diagnosis of depressive and/or anxiety disorders in three 
studies.
Stepped care treatment. The stepping-up criteria were diverse across the four included treatment studies 
(Table 2). One of the studies18 adopted stringent criteria, with a combination of three self-report assessments, 
including Inventory of Depressive Symptomatology (IDS) ≥ 14, Hospital Anxiety and Depression Scale (HADS) 
≥ 8, and Work and Social Adjustment Scale (WSAS) ≥ 6. The other 3 studies used Beck Anxiety Inventory (BAI) 
> 11 or less than 50% score reduction16, Clinical Global Impression-Severity Scale (CGI-S) ≥ 336, or the Yale–
Brown Obsessive–Compulsive Scale (Y-BOCS) > 1319. Serious cases were referred to the last step if the following 
criteria were fulfilled: WSAS ≥ 8 on 3 of the 4 daily functioning domains, depression with psychotic features or 
suicidal ideation, or Y-BOCS > 13. One of the included studies did not report the direct referral requirement 
(Study 4)16.
Attrition Rate and Reasons for Attrition. Stepped care prevention. Attrition rate was reported in all 
included prevention studies; however, the assessment time points were different across studies (Table 2). Three 
of the four studies reported the attrition rates in both groups. The average cumulative attrition rates of stepped 
care prevention were 15.0% at posttreatment, and the corresponding rate of CAU was only reported in 3 included 
studies, which was 8.9% at posttreatment. There was significant difference between stepped care prevention group 
and CAU group in attrition rate (risk ratio: 1.7, 95% CI: 1.2 to 2.4, p < 0.01 I2 = 40%, N = 3). Reasons for attrition 
were reported in all four studies. The most commonly cited reasons were physical illness and death, which might 
be due to the advanced age of the target population.
Stepped care treatment. Attrition rate was reported in three of the four included treatment studies (Table 2). Of 
the three treatment studies, two reported the attrition rates of both stepped care and CAU groups. The average 
cumulative attrition rates of stepped care treatment were 19.4% at posttreatment, and the corresponding rates of 
CAU were 5.0%. No significant difference was found between stepped care treatment group and CAU group in 
attrition rate (risk ratio: 1.9, 95% CI: 0.9 to 4.3, p = 0.11, I2 = 0%, N = 2). The dropouts provided various attrition 
reasons including unwillingness to complete assessment, contact failure, and physical illness.
Quality Assessment. Cochrane’s risks of bias assessment. There were some methodological flaws in all of 
the included studies (Supplementary Table S2). Due to the nature of the study, it made blinding of participants 
improbable, and thus the risk of bias was assessed as “high” in all included studies. On the other hand, because 
the independent assessor was usually masked from the conditions, the risk of bias for blinding of assessor was 
generally assessed as “low.” The majority of studies did not report the allocation concealment method and thus 
Questionnaire; FTF, face-to-face; FU, follow-up; GAD, generalized anxiety disorder; GARS, Groningen Activity 
Restriction Scale; GGZ, GGZ thermometer; HADS-A, Hospital Anxiety and Depression Scale–Anxiety; HRSA, 
Hamilton Rating Scale for Anxiety; IDS, Inventory of Depressive Symptomatology; MDD, major depressive 
disorder; MINI, Mini International Neuropsychiatric Interview; NR, not reported; OCD, obsessive-compulsive 
disorder; PD, panic disorder; PHQ, Patient Health Questionnaire; PST, problem-solving treatment; SC, stepped 
care; SCL-90-R, Symptom Checklist–90–Revised; SF-36, Short-Form Health Survey–36 items; SH, self-help; 
Tic-P, Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness; WSAS, Work and Social 
Adjustment Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale.
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the risk of bias were rated as “uncertain.” In addition, all included studies were free of bias in selective reporting 
and other possible biases.
Meta-analyses. Stepped care prevention vs. CAU. The incidence rate of anxiety and/or depressive disorders 
in stepped care prevention did not differ significantly from CAU (Fig. 2; OR = 0.75, 95% CI: 0.41, 1.38, p = 0.36, 
I2 = 45%, N = 3), indicating that the chances of developing anxiety and/or depressive disorders in stepped care 
group and CAU group were similar.
Stepped care treatment vs. CAU. At immediate posttreatment, the pooled analysis of three RCTs found that 
stepped care treatment was significantly better than CAU in reducing anxiety symptoms (Fig. 3; standardized 
mean difference = − 0.29, 95% CI: − 0.48, − 0.10, p < 0.01, I2 = 0%). The pooled treatment response rate of anxiety 
disorders in two RCTs was significantly higher in stepped care treatment than in CAU (Supplementary Fig. S2; 
OR = 2.38, 95% CI: 1.25, 4.52, p < 0.01, I2 = 0%). No significant difference was found between stepped care treat-
ment and CAU in improving depressive symptoms.
No.
Study authors 
(year) Treatment content Recruitment Cumulative attrition rate (step no./assessment)
Stepping up criteria (direct to the 
last step)
Stepped Care Prevention
1 Apil et al.30,31
Step 2–SH CBT:
Based on Coping with Depression (book)
Step 3–FTF CBT:
Individual Coping with Depression course
Psychiatric center SC: 16.9% (PT)CAU: NR
CES-D > 15 (diagnosis of depression 
by MINI)
2 Dozeman  et al.32
Step 2–SH activity-scheduling:
Based on Coping with Depression (book)
Step 3–FTF life review:
Based on Life Review Therapy Using Autobiographical 
retrieval Practice for Older Adults with Depressive 
Symptomatology
Residential homes SC: 18.9% (PT)CAU: 10.8% (PT)
CES-D < 5 improvement (DSM-IV 
diagnosis of depressive or anxiety 
disorder)
3
van’t Veer-
Tazelaar  
et al.33,34
Step 2–SH CBT:
Based on Coping with Depression (book)
Step 3–FTF PST:
A brief CBT that focuses on practical skill building 
and help regaining control of patients’ lives.
Primary care
SC: 11.8% (6 mo-PT), 14.7% (12 mo-FU), 15.3% 
(18 mo-FU), 15.9% (24 mo-FU)
CAU: 4.1% (6 mo-PT), 4.7% (12 mo-FU), 5.9% (18 
mo-FU), 8.2% (24 mo-FU)
CES-D ≥ 16 (diagnosis of depressive 
or anxiety disorders by MINI)
4 Zhang et al.35
Step 2–Guided SH instruction through telephone:
Based on Theory and Practice of Counseling and 
Psychotherapy, Theories in Counseling and Therapy: 
An Experiential Approach and Assessing Families and 
Couples: From Symptom to System (books)
Step 3–FTF PST:
Based on Problem-solving therapy: A social 
competence approach to clinical intervention and 
Problem Solving Therapy
Primary clinics
SC: 6.6% (3 mo), 10.7% (6 mo), 10.7% (9 mo), 
12.4% (12 mo-PT), 14.0% (15 mo-FU)
CAU: 6.7% (3 mo), 8.4% (6 mo), 10.9% (9 mo), 
11.8% (12 mo-PT), 15.1% (15 mo-FU)
CES-D ≥ 16 or HADS-A ≥ 6, without 
the SCID diagnosed MDD or GAD 
(NR)
Stepped Care Treatment
5 Muntingh  et al.16
Step 1–Guided SH CBT:
Provided with psychoeducation, cognitive 
behavioural exercises and a guided relaxation CD 
(book) + consultation
Step 2–FTF CBT:
Cognitive therapy and exposure+ workbook
Primary care NR BAI > 11 or BAI < 50% score reduction (NR)
6 Oosterbaan et al.36
Step 1–Guided SH CBT:
Depression: Based on Coping with Depression 
Anxiety: Based on Stresspac (book)
Mental health 
care center
SC: 8.9% (PT), 16.5% (FU)
CAU: 3.2% (PT), 7.6% (FU)
CGI-S ≥ 3 (depression with psychotic 
features, actively suicidal or family of 
the patient was overly strained due to 
psychiatric disorder)
7 Seekles  et al.18
Step 2–Guided SH CBT:
PST (book/Internet)/Exposure therapy for phobia 
(book) + feedback
Step 3–FTF PST:
Based on Problem Solving Treatment for Anxiety and 
Depression: A Practical Guide
Mental health 
centers
SC: 29.2% (PT)
CAU: NR
IDS ≥ 14, HADS ≥ 8 and WSAS ≥ 
6 (WSAS ≥ 8 on 3 of the 4 daily 
functioning domains)
8 Tolin et al.19
Step 1–Guided SH ERP:
Based on Stop Obsessing!: How to Overcome Your 
Obsessions and Compulsions (book)
Step 2–FTF ERP:
Based on Mastery of Obsessive-Compulsive Disorder: 
A Cognitive-Behavioral Approach (Therapist Guide)
NR SC: 20.0% (PT)CAU: 6.7% (PT) Y-BOCS > 13 (Y-BOCS > 13)
Table 2.  Source of Treatment Content, Treatment Type, Recruitment Method, Attrition Rate, Reasons 
for Attrition, and Stepping Up Criteria. BAI, Beck Anxiety Inventory; CAU, care-as-usual; CBT, cognitive-
behavioral therapy; CES-D, Centre of Epidemiological Studies–Depression scale; CGI-S, Clinical Global 
Impression–Severity Scale; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition; FTF, face-to-face; FU, follow-up; GAD, generalized anxiety disorder; HADS, Hospital Anxiety and 
Depression Scale; IDS, Inventory of Depressive Symptomatology; MDD, major depressive disorder; MINI, 
Mini International Neuropsychiatric Interview; NR, not reported; PST, problem-solving treatment; PT, 
posttreatment; SC, stepped care; SCID, Structured Clinical Interview for DSM-IV; SH, self-help; WSAS, Work 
and Social Adjustment Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale.
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Cost-effectiveness. Among the included stepped care prevention studies, two reported data on 
cost-effectiveness (Study 2 and 3)38,39. Both studies evaluated stepped care prevention in the older popula-
tion. In Study 2, the cost estimate was derived from Trimbos and Institute of Medical Technology Assessment 
Questionnaire (TIC-P) at each prevention step38. It demonstrated that there was no significant difference in total 
mean cost between stepped care prevention (€4,284) and CAU (€3,446), and the prevention was not considered 
cost-effective when comparing with CAU in elderly. Study 3 found that stepped care prevention halved the inci-
dence rate of depression and anxiety at an incremental cost of €563 per recipient and an average of €4,367 for a 
depression/anxiety-free year39. The cost was estimated based on the healthcare uptake measured by the TIC-P and 
out-of-pocket expenses from patients at each prevention step. The study concluded that the stepped care preven-
tion allowed depression/anxiety-free survival years in elderly at an affordable cost. Data on productivity cost was 
considered irrelevant in the older population. Hence, it was not included in the cost-effectiveness analysis in both 
studies. Cost-effectiveness was not examined in any of the treatment studies that were included.
Publication Bias. Funnel plots for the comparison of stepped care prevention or treatment and CAU were 
not possible due to the small number of included studies; hence, publication bias could not be determined.
Discussion
Stepped care model is an emerging delivery method in preventing and treating depression and anxiety disor-
ders. The aim of this review study was to compare the efficacy and cost-effectiveness between stepped care and 
CAU groups. The comparison of stepped care treatment and CAU revealed significant difference in favor of the 
former in terms of anxiety symptoms and treatment response rate of anxiety disorders. Significant difference 
was not found between stepped care prevention/treatment and CAU in preventing anxiety and/or depressive 
disorders and reducing depressive symptoms. Cost-effectiveness analysis demonstrated inconsistent findings 
between stepped care prevention and CAU in two studies, with one considered effective at an affordable cost but 
not the other. Overall, there was evidence showing that stepped care treatment is effective in alleviating anxiety 
symptoms.
In our meta-analysis, sample sizes merged from multiple studies increased the chance of detecting the differ-
ence of treatment effect between the two groups, if any. On the other hand, stepped care prevention had signifi-
cantly higher attrition rate than CAU, perhaps patients in the stepped care group lost their interest and patience 
to step up. The included studies had various treatment components at each step and a wide range of stepping-up 
criteria, which may have affected the treatment effect of the whole treatment model. Nonetheless, the hetero-
geneity test in the meta-analysis of stepped care treatment indicated no observed statistical heterogeneity (i.e., 
I2 = 0%); therefore, the detected treatment effect was likely to be genuine, given the high level of consistency 
across the studies40.
To date, there is no consensus on the structure of the stepped care model. Indeed, other than the fact that 
they all included self-help as a treatment component, the RCTs included in the current review have different 
combinations, sequences, and number of steps in their rendition of the model. Although there might be merit 
to standardize the architecture of the model, we argue that flexibility is also needed to adequately respond to the 
differences in resource availability and logistical constraints across diverse settings. As such, stepped care model, 
we argue, should be evaluated as a whole, and not independently at each step. Researchers are encouraged to 
focus their attention on constructing the most feasible model in response to the needs and available resources of 
the particular setting. Nevertheless, there remains a need to select evidence-based treatments as the basis of the 
model, such as, but not limited to, CBT41,42, PST43, behavioral activation44, and mindfulness and acceptance-based 
treatments45. Generally, the delivery modality of these evidence-based treatments comprises self-help therapy, 
guided group therapy, brief and long-term individual therapy. In terms of number of steps in the model, the pre-
vention studies we included generally had four steps, whereas treatment studies adopted two to four steps. The 
optimal number of steps can vary under different circumstances. Two major factors—the intensity of treatment 
and the upper limit of therapist input in a routine healthcare setting—can help to determine how many steps 
should be included15.
Self-correcting is one of the key features on the health gain and patients’ progress15. It is underscored 
that whether or not a model is cost-effective may partly depend on the stepping-up criteria8. A well-defined 
stepping-up criterion should be sensitive enough to detect those who fail to respond to the first-line treatments, 
so that the model is able to maximize the proportion of patients who may benefit from the low-intensity first-line 
interventions. On the one hand, it should be able to rapidly identify and provide appropriate treatment to patients 
in need of more intensive care.
The heterogeneity of the stepping-up criteria among the included studies did not allow us to draw a conclu-
sion on a best-fit assessment tool or cut-off score. Conventional questionnaires for screening depression and/or 
anxiety, such as CES-D46, BDI47, BAI48, and HADS49, can be considered as screening tools. The cut-off score can 
be decided based on previous validation studies with good sensitivity and specificity analyses. Nonetheless, there 
is room for cut-off score adjustment depending on the nature of trial. For example, relative to treatment studies, 
prevention studies tend to recruit high-risk populations who do not meet full criteria for a diagnosis. For this 
reason, prevention studies might have relatively more conservative cut-off scores whereas treatment studies might 
adopt more stringent cut-off scores. Alternatively, the option for clinician administrated structured diagnostic 
assessments is more desirable. Nonetheless, the additional therapist time and cost may undermine the core fea-
ture (i.e. least restrictive) of the stepped care model.
There were several limitations in our study. First, the number of studies included in the meta-analysis was 
small. Since stepped care for depression and anxiety is a relatively new area of research, only few trial studies have 
been completed. The exclusion of non-self-help treatment at the entry step also reduced the amount of studies. 
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Nevertheless, since the step care model varied greatly across studies, the inclusion of stepped care studies regard-
less of their model design may hinder the comparison between studies. We encourage researchers to interpret 
the current findings with caution, and extend and replicate the current findings in the future to provide further 
evaluations for stepped care.
Second, the variation of treatment effect among studies might be related to different model structures. The 
content, duration, sequence and delivery method of treatment might have an impact on the treatment outcome. 
In addition, the diversity of diagnostic criteria and age groups in the included studies may also contribute to 
the variation in the treatment outcome. Finally, most of the included studies were from healthcare systems in 
European or American contexts, with the majority of trials conducted in the Netherlands. It is unknown whether 
the stepped care model is applicable or generalizable to healthcare systems in emerging countries where resources 
for mental health might be scarce. To date, no studies examining the efficacy of stepped care for depressive and 
anxiety disorders have been conducted in emerging countries with very limited mental healthcare resources.
In response to the high demand yet simultaneously limited resources for mental health services, the stepped 
care model for common mental health disorders is of increasing relevance around the globe. The result in this 
review study sheds light on the efficacy and cost-effectiveness of stepped care model in preventing and treating 
depressive and/or anxiety disorders. The model has the potential to reduce the burden on existing resources in 
mental health and at the same time increase the reach and availability of service. The model might also be of 
particular interest in regions where stigma is preventing those in need of mental health services to seek help. The 
lower steps in the stepped care model may be less stigmatizing than full-blown psychotherapy or psychiatric care. 
We suggest further fine-tuning of the stepped care model with the utilization of technology to further enhance its 
efficacy and efficiency. A smartphone application, for example, might be a favourable platform to support patients 
in clinical settings50. It can even serve as a tool used in the first step (e.g., self-help). Emerging countries have 
become more aware of the importance of mental health service. Unfortunately, investment on resources continues 
to be lacking51. Stepped care model serves as an economically viable and effective treatment option.
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